Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis

被引:339
作者
Gertz, Morie A. [1 ]
Benson, Merrill D. [2 ]
Dyck, Peter J. [3 ]
Grogan, Martha [4 ]
Coelho, Terresa [5 ]
Cruz, Marcia [6 ]
Berk, John L. [7 ]
Plante-Bordeneuve, Violaine [8 ]
Schmidt, Hartmut H. J. [9 ]
Merlini, Giampaolo [10 ]
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[3] Mayo Clin, Div Peripheral Nerve, Rochester, MN 55905 USA
[4] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA
[5] Hosp Santo Antonio, Oporto, Portugal
[6] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil
[7] Boston Univ, Sch Med, Amyloidosis Ctr, Boston, MA 02118 USA
[8] Univ Hosp, Creteil, France
[9] Univ Klinikum Munster, Munster, Germany
[10] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy
关键词
familial amyloid cardiomyopathy; familial amyloid polyneuropathy; genetics; liver transplantation; SENILE SYSTEMIC AMYLOIDOSIS; WILD-TYPE TRANSTHYRETIN; LATE GADOLINIUM ENHANCEMENT; SEVERE CARDIAC AMYLOIDOSIS; LIVER-TRANSPLANTATION; HEART-TRANSPLANTATION; MAGNETIC-RESONANCE; NATRIURETIC PEPTIDE; LONG-TERM; CARDIOVERTER-DEFIBRILLATOR;
D O I
10.1016/j.jacc.2015.09.075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transthyretin amyloidosis is a fatal disorder that is characterized primarily by progressive neuropathy and cardiomyopathy. It occurs in both a mutant form (with autosomal dominant inheritance) and a wild-type form (with predominant cardiac involvement). This article guides clinicians as to when the disease should be suspected, describes the appropriate diagnostic evaluation for those with known or suspected amyloidosis, and reviews the interventions currently available for affected patients. (C) 2015 by the American College of Cardiology Foundation.
引用
收藏
页码:2451 / 2466
页数:16
相关论文
共 129 条
[1]   Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy [J].
Ackermann, Elizabeth J. ;
Guo, Shuling ;
Booten, Sheri ;
Alvarado, Luis ;
Benson, Merrill ;
Hughes, Steve ;
Monia, Brett P. .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 :43-44
[2]   Regional difference and similarity of familial amyloidosis with polyneuropathy in France [J].
Adams, David ;
Lozeron, Pierre ;
Theaudin, Marie ;
Mincheva, Zoia ;
Cauquil, Cecile ;
Adam, Clovis ;
Signate, Aissatou ;
Vial, Christophe ;
Maisonobe, Thierry ;
Delmont, Emilien ;
Franques, Jerome ;
Vallat, Jean-Michel ;
Sole, Guilhem ;
Pereon, Yann ;
Lacour, Arnaud ;
Echaniz-Laguna, Andoni ;
Misrahi, Micheline ;
Lacroix, Catherine .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 :61-64
[3]   Prophylactic pacemaker implantation in familial amyloid polyneuropathy [J].
Algalarrondo, Vincent ;
Dinanian, Sylvie ;
Juin, Christophe ;
Chemla, Denis ;
Bennani, Soumiya L. ;
Sebag, Claude ;
Plante, Violaine ;
Le Guludec, Dominique ;
Samuel, Didier ;
Adams, David ;
Slama, Michel S. .
HEART RHYTHM, 2012, 9 (07) :1069-1075
[4]   Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: State of the art review and focus on emerging nuclear techniques [J].
AlJaroudi, Wael A. ;
Desai, Milind Y. ;
Tang, W. H. Wilson ;
Phelan, Dermot ;
Cerqueira, Manuel D. ;
Jaber, Wael A. .
JOURNAL OF NUCLEAR CARDIOLOGY, 2014, 21 (02) :271-283
[5]  
ALMEIDA MR, 1995, HUM GENET, V96, P350
[6]   Guideline of transthyretin-related hereditary amyloidosis for clinicians [J].
Ando, Yukio ;
Coelho, Teresa ;
Berk, John L. ;
Cruz, Marcia Waddington ;
Ericzon, Bo-Goran ;
Ikeda, Shu-ichi ;
Lewis, W. David ;
Obici, Laura ;
Plante-Bordeneuve, Violaine ;
Rapezzi, Claudio ;
Said, Gerard ;
Salvi, Fabrizio .
ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
[7]   Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis An Equilibrium Contrast Cardiovascular Magnetic Resonance Study [J].
Banypersad, Sanjay M. ;
Sado, Daniel M. ;
Flett, Andrew S. ;
Gibbs, Simon D. J. ;
Pinney, Jennifer H. ;
Maestrini, Viviana ;
Cox, Andrew T. ;
Fontana, Marianna ;
Whelan, Carol J. ;
Wechalekar, Ashutosh D. ;
Hawkins, Philip N. ;
Moon, James C. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (01) :34-39
[8]   Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides [J].
Benson, MD ;
Kluve-Beckerman, B ;
Zeldenrust, SR ;
Siesky, AM ;
Bodenmiller, DM ;
Showalter, AD ;
Sloop, KW .
MUSCLE & NERVE, 2006, 33 (05) :609-618
[9]   Liver transplantation and transthyretin amyloidosis [J].
Benson, Merrill D. .
MUSCLE & NERVE, 2013, 47 (02) :157-162
[10]   Repurposing Diflunisal for Familial Amyloid Polyneuropathy A Randomized Clinical Trial [J].
Berk, John L. ;
Suhr, Ole B. ;
Obici, Laura ;
Sekijima, Yoshiki ;
Zeldenrust, Steven R. ;
Yamashita, Taro ;
Heneghan, Michael A. ;
Gorevic, Peter D. ;
Litchy, William J. ;
Wiesman, Janice F. ;
Nordh, Erik ;
Corato, Manuel ;
Lozza, Alessandro ;
Cortese, Andrea ;
Robinson-Papp, Jessica ;
Colton, Theodore ;
Rybin, Denis V. ;
Bisbee, Alice B. ;
Ando, Yukio ;
Ikeda, Shu-ichi ;
Seldin, David C. ;
Merlini, Giampaolo ;
Skinner, Martha ;
Kelly, Jeffery W. ;
Dyck, Peter J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (24) :2658-2667